filmov
tv
Moderna Has Chance to Be ‘Vaccine of Choice’: Johns Hopkins
![preview_player](https://i.ytimg.com/vi/0BCDmUC5ur0/sddefault.jpg)
Показать описание
Nov.17 -- Johns Hopkins Center for Health Security Senior Scholar Dr. Amesh Adalja discusses vaccine options from Moderna Inc. and Pfizer Inc. and rising hospitalizations in the U.S. He speaks with Bloomberg’s Francine Lacqua on "Bloomberg Surveillance." The Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder and majority owner of Bloomberg LP, the parent company of Bloomberg News.
Moderna Has Chance to Be ‘Vaccine of Choice’: Johns Hopkins
Moderna’s Covid Vaccine Receives Full Approval From U.S. FDA
Moderna’s Covid Vaccine Bolsters Immune Response in Kids Under 6
Moderna CEO Stéphane Bancel - Bringing Exponentials to Pharma
Moderna Vaccine Had Decade Head Start Over Pfizer: Chairman
FDA Clears Pfizer, Moderna Covid Boosters for Omicron Variants
Indy doctor talks chances of Moderna vaccine for kids getting approved
Video: Boston doctor talks about possibility of Moderna COVID-19 vaccine use in kids ages 12-15
Answering your questions about the Moderna vaccine
Moderna CEO Hopes to Get Vaccine Approval in Next Few Weeks
Study: Pfizer, Moderna vaccines likely produce long lasting immunity
Coronavirus vaccine: Moderna CEO discusses vaccine development
MIT Professor’s Moderna Stake on Brink of Topping $1 Billion
Moderna Vaccine Arrives at U.S. Hospitals
Moderna COVID-19 vaccine patent dispute headed to court
Moderna vaccine seen as opportunity for rural hospitals
Moderna CEO: ‘80% chance that the world slowly goes back to normal for most people’
North Texas teacher shares experience after participating in Moderna COVID-19 vaccine
40 Million Moderna, Pfizer Vaccines Expected in U.S. by the End of the Month
Indy doctor talks chances of Moderna vaccine for kids getting approved
Coronavirus vaccine: Moderna CEO breaks down emergency use authorization, distribution, and efficacy
How important is the booster shot for Pfizer and Moderna vaccines?
Analysis: Moderna Vaccine Found Safe, Effective Ahead of Key FDA Review
Moderna's Vaccine Protects Against Covid For At Least Six Months: Study
Комментарии